At a Crossroads FDA Workforce Crisis Threatens Drug Innovation, Public Health, and Regulatory Stability The recent wave of layoffs and resignations within the U.S. Food and Drug Administration (FDA) has

RFK Jr ‘s FDA Navigating the Shiftin g Sands of FDAMA 3.0   The FDA Modernization Act 3.0 (FDAMA 3.0) isn’t a single piece of legislation but an ongoing effort